ALT FY 2014 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$335M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-43.1% YoY

Gross Profit

$6M58.1% margin

Operating Income

-$10M-100.0% margin

Net Income

-$10M-97.7% margin

EPS (Diluted)

$-51.91

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$22M

Total Liabilities

$4M

Stockholders' Equity

$18M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$18M	-43.1%
Gross Profit	$6M	$18M	-66.9%
Operating Income	-$10M	-$11M	+6.0%
Net Income	-$10M	-$12M	+15.0%